Focuses on the Consolidation for Leading Projects
Accelerates Clinical Trials for Core Products STP705, STP707 and STP122G
HONG KONG, Germantown, Md. and SUZHOU, China, March 28, 2024 /PRNewswire/.
/PRNewswire/ Sirnaomics Ltd. (the "Company"; together with its subsidiaries, the "Group" or "Sirnaomics"; stock code: 2257), a leading biopharmaceutical.
Sirnaomics Announces 2022 Annual Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.